Strong Capital Position After FRTB Implementation
Completed transition to FRTB in November 2025 ahead of schedule; market risk RWA decreased by 16% leading to a CET1 ratio of 16.9% (approx. +270 bps impact). Board plans a share buyback in early 2027 provided CET1 remains meaningfully above 15%.
Material Cost Reductions and Efficiency Actions
Underlying operating expenses decreased by CHF 36 million or 16% to CHF 194 million in 2025; reported costs down CHF 25 million or 11%. Personnel expenses reduced by CHF 20 million, headcount down 7%, contractors down 24%, and variable compensation for 2025 reduced by >50%.
Improved Client Momentum in H2 2025
Client transactions increased 14% to more than 140,000 in H2; a record 33,000 products were issued on the platform in H2 2025; market share in structured investment products in Switzerland rose to 29% in H2 2025.
Retail Flow (RFB) Business Traction
Entered Swiss listed leverage products market in April 2025, offering >10,000 listed leverage products and achieving ~7% market share in the offered categories within eight months. RFB generated ~CHF 3 million revenues in 2025 and is budgeted to deliver ~CHF 8 million in 2026; BaFin approval for Germany received, go-live planned Q2 2026 with further country rollouts planned (e.g., Italy).
Successful Growth in Specific Product Areas (AMCs, LYNQS, Issuer Flow)
Outstanding volume of new-generation AMCs rose ~46% year-on-year to ~CHF 0.3 billion; total AMC outstanding CHF 2.3 billion (-5% YoY) with recurring revenues CHF 28.3 million in H2 (broadly flat vs H2 2024). Products initiated via LYNQS increased 90% to 11,087 in H2 with click 'n' trade ratio improving to 33% (from 26%). Turnover in Leonteq-issued products rose 23% to CHF 7.5 billion in H2; Tier 1 turnover +7% to CHF 4.5 billion and Tier 2/3 +42% to CHF 1.7 billion in H2.
Balance Sheet and Liquidity Actions
Total assets increased by CHF 0.5 billion to CHF 11.2 billion. Investment portfolio stable at CHF 2.7 billion but shifted to higher-quality liquid assets in preparation of business-specific liquidity regime; issued products increased 2% to CHF 5.3 billion, indicating continued client demand.
Strategic Progress on ROE Plan and Leadership
Executed 'Resize, Optimize, Expand' strategic priorities with focus on resizing and optimizing in 2025; nomination of Felix Oegerli as proposed Independent Chairman (bringing deep trading, prime finance and capital markets experience). Management expects to return to positive pretax result for H1 and full year 2026 and to achieve mid-term targets in 2028.
Regulatory and Legacy Remediation Completed or Advanced
Transition to the new regulatory regime completed, FINMA remediation addressed and BaFin legacy matter closed; one remaining EU regulatory matter has been remediated and is expected to close, reducing regulatory uncertainty and freeing management capacity.